IBM Watson Health Imaging's Patient Synopsis went live at Hardin Memorial Health in Elizabethtown, Ky., on May 6, making the health system the first to implement the artificial intelligence-powered software.
Innovation
To overcome challenges of fraudulent activity and digital transactions, the insurance industry is beginning to introduce blockchain, which is designed to bring accountability, security and transparency to the industry, according to Yahoo Finance.
The first artificial intelligence-enabled device for diagnosing and managing fast-progressing kidney disease has been granted "Breakthrough Device" designation from the FDA, Cardiff, U.K.-based clinical technology company Renalytix AI announced on May 2.
A new report in Nature details the efforts of scientists at the University of California's San Francisco and Berkeley campuses to translate brain signals into an approximation of natural speech, a groundbreaking process that, with further development, could restore fluent…
AliveCor, the Mountain View, Calif.-based artificial intelligence and medtech company, has received FDA clearance for two more analyses on its AI-powered KardiaMobile electrocardiogram (ECG) device.
Advertisement
A new study published in Science Translational Medicine describes the work of researchers at San Diego's Rady Children's Institute for Genomic Medicine to rapidly diagnose genetic diseases using whole-genome sequencing.
A new study published in JAMA Oncology shows that artificial intelligence systems crowdsourced from data scientists can segment lung tumors as accurately as human experts can, and at much higher speeds.
A shuttle between Connecticut-based Yale New Haven Hospital's two main campuses and parking facilities could be completely driverless within just a few years, if the city's application to a state pilot program is approved, the New Haven Register reports.
An artificial intelligence screening system developed by scientists at Harvard Medical School in Cambridge, Mass., can identify homologous recombination deficiency, a cancer-causing genetic defect that often goes undetected, according to a press release. If integrated into widespread use, the AI…
Health insurer Centene has pledged $100 million to Washington University in St. Louis to advance research on personalized treatments for conditions like Alzheimer's, breast cancer, diabetes and obesity.